Literature DB >> 21647678

Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.

G W Huang1, X Ding, S L Chen, L Zeng.   

Abstract

PURPOSE: To investigate the expression of claudin 10 in hepatocellular carcinoma (HCC) and the impact on angiogenesis and the postoperative survival of HCC patients.
METHODS: The expression of claudin 10 protein was analyzed on samples from 99 HCC patients undergoing hepatectomy with immunohistochemistry and 31 fresh specimens with Western blotting. We examined the relationship between claudin 10 expression with clinicopathological factors, microvessel density (MVD), and postoperative survival.
RESULTS: Western blotting and immunohistochemical staining showed that claudin 10 protein was highly expressed in HCC, compared with paraneoplastic liver tissue and normal liver tissue (P < 0.01). Claudin 10 protein expression levels were significantly higher in HCC specimens with microscopic venous invasion (P < 0.01). MVD in HCC increased with enhanced claudin 10 expression (P < 0.01). Kaplan-Meier survival analysis revealed that HCC patients with high claudin 10 expression had significantly shorter overall survival (P = 0.01). Multivariate analysis showed that claudin 10 expression was an independent prognostic indicator for postoperative overall survival of HCC patients (P < 0.01).
CONCLUSIONS: Claudin 10 protein is highly expressed in HCC tissue and is closely related to angiogenesis. Claudin 10 protein could be a useful marker to predict poor prognosis of HCC patients after hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647678     DOI: 10.1007/s00432-011-0987-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Recurrence of hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

2.  Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Authors:  Michio Sugita; Mark Geraci; Bifeng Gao; Roger L Powell; Fred R Hirsch; Gary Johnson; Razvan Lapadat; Edward Gabrielson; Roy Bremnes; Paul A Bunn; Wilbur A Franklin
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

3.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

4.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

5.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.

Authors:  Murray B Resnick; Tamako Konkin; Justin Routhier; Edmond Sabo; Victor E Pricolo
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

6.  Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Yi-Ming Tao; Xiang Ding
Journal:  Dig Dis Sci       Date:  2008-07-01       Impact factor: 3.199

7.  Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma.

Authors:  Suk Mei Wang; London Lucien P J Ooi; Kam M Hui
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

8.  Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.

Authors:  Alessandro D Santin; Fenghuang Zhan; Stefania Bellone; Michela Palmieri; Stefania Cane; Eliana Bignotti; Simone Anfossi; Murat Gokden; Donna Dunn; Juan J Roman; Timothy J O'Brien; Erming Tian; Martin J Cannon; John Shaughnessy; Sergio Pecorelli
Journal:  Int J Cancer       Date:  2004-10-20       Impact factor: 7.396

9.  Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Authors:  Y-L Choi; J Kim; M J Kwon; J S Choi; T-J Kim; D-S Bae; S S Koh; Y-H In; Y W Park; S H Kim; G Ahn; Y K Shin
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  14 in total

Review 1.  AVP dynamically increases paracellular Na+ permeability and transcellular NaCl transport in the medullary thick ascending limb of Henle's loop.

Authors:  Nina Himmerkus; Allein Plain; Rita D Marques; Svenja R Sonntag; Alexander Paliege; Jens Leipziger; Markus Bleich
Journal:  Pflugers Arch       Date:  2016-12-06       Impact factor: 3.657

2.  Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.

Authors:  Weiwei Weng; Meng Zhang; Shujuan Ni; Cong Tan; Midie Xu; Xin Wang; Hui Sun; Lei Wang; Dan Huang; Weiqi Sheng
Journal:  J Gastrointest Oncol       Date:  2022-06

3.  Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.

Authors:  Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Attila Szijártó; Péter Kupcsulik; Zsuzsa Schaff; András Kiss
Journal:  J Histochem Cytochem       Date:  2013-02-05       Impact factor: 2.479

4.  Tricellulin expression and its prognostic significance in primary liver carcinomas.

Authors:  Aron Somorácz; Anna Korompay; Péter Törzsök; Attila Patonai; Boglárka Erdélyi-Belle; Gábor Lotz; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2014-03-21       Impact factor: 3.201

5.  Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins.

Authors:  Ellen C Kammula; Jessica Mötter; Alexandra Gorgels; Esther Jonas; Silke Hoffmann; Dieter Willbold
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

6.  Expression of claudin-5, claudin-7 and occludin in oral squamous cell carcinoma and their clinico-pathological significance.

Authors:  Ekarat Phattarataratip; Kraisorn Sappayatosok
Journal:  J Clin Exp Dent       Date:  2016-07-01

7.  Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.

Authors:  Rou Chen; Qingzhou Guan; Jun Cheng; Jun He; Huaping Liu; Hao Cai; Guini Hong; Jiahui Zhang; Na Li; Lu Ao; Zheng Guo
Journal:  Oncotarget       Date:  2017-01-24

Review 8.  Tight Junction Proteins and the Biology of Hepatobiliary Disease.

Authors:  Natascha Roehlen; Armando Andres Roca Suarez; Houssein El Saghire; Antonio Saviano; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

9.  Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer.

Authors:  Qiang Wang; Yan Zhang; Tao Zhang; Zhi-Gang Han; Li Shan
Journal:  Onco Targets Ther       Date:  2015-07-31       Impact factor: 4.147

Review 10.  The claudin family of proteins in human malignancy: a clinical perspective.

Authors:  Lei Ding; Zhe Lu; Qun Lu; Yan-Hua Chen
Journal:  Cancer Manag Res       Date:  2013-11-08       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.